32nd Congress of the ESP and XXXIII International Congress of the IAP
Glasgow 2020: A Vision for the Future
29 August – 2 September 2020 | Glasgow, UK
ESP website
32nd ESP Congress & XXXIII IAP Congress in Glasgow
Congress
ECP 2019 Nice
Presentations
Tuesday, 10 September 2019
Congress
Welcome Address
General Information
Welcome to Glasgow
Downloads
Related Meetings / Media Partners
Committees & Organiser
CME Accreditation
Congress Newsletter
ECP 2019 Nice
Gallery
Awardees
Industry Partners
Presentations
Sunday, 8 September 2019
Monday, 9 September 2019
Tuesday, 10 September 2019
Wednesday, 11 September 2019
Abstracts
Guidelines for Submission
Bursaries
Format Descriptions
Best Oral and Poster Prizes
Registration & Hotels
Registration Fees
Group Registration
Accommodation
Online Registration
Scientific Programme
Scientific Contents
Sponsors & Exhibitors
General Information
My Account
Create Account
Congress Account
Sunday, 8 September 2019
Monday, 9 September 2019
Tuesday, 10 September 2019
Wednesday, 11 September 2019
Tuesday, 10 September 2019
08:30 - 12:00
LC-04 | Paediatric and Perinatal Pathology: Update on vascular anomalies of childhood
LC-04-001-Update of the ISSVA classification
LC-04-002-Benign vascular tumours
LC-04-003-Borderline and malignant vascular tumours
LC-04-006-Provisionally unclassified vascular anomalies
MD-05 | Selected abstracts
MD-05-001-Differentially expressed immune related genes in metastatic vs. non-metastatic LUMA, LUMB1 and TNBC primary breast carcinoma cases
MD-06 | Mutational signatures and bioinformatics
MD-06-001-Signal: the homepage of mutational signatures
MD-06-002-A new user-friendly web application to implement mutational signatures analysis
OFP-09 | Joint Session: Autopsy Pathology / Cardiovascular Pathology / History of Pathology / IT in Pathology / Pathology in Favour of Developing Countries / Other Topics
OFP-09-001-Adult clinical necropsies: the gold standard of clinical practice are decreasing worldwide. And in Coimbra? A retrospective study from 2007 to 2018 comparing clinical and autopsy diagnoses
OFP-09-002-Morphological and virological diagnostics of myocarditis in patients with hypertrophic cardiomyopathy
OFP-09-003-Canonical recognition and on-site palaeopathologic study of the Blessed Vincenzo dell'Aquila (1430-1504)
OFP-09-004-Paleopathology of two mummified bodies from the Takarkori rock shelter (SW Libya, 6100-5600 years BP)
OFP-09-005-Histopathology and DNA evaluation of wet specimens from the Pathology Collection of Turin
OFP-09-006-The historical roots of theranostic revealed by the genealogical and phylogenetic portrayal of tumours by pathologists
OFP-09-007-Scorenado: a customisable, user-friendly and open-source visual assessment tool for histological slides
OFP-09-008-Complete digital pathology for routine histopathology diagnosis: 2 years' experience at Granada University Hospitals, Spain
OFP-09-009-Digital immunohistochemical evaluation of PDL1 in lung carcinomas highly correlates with manual method
OFP-09-011-Pathology teaching: the use of art and active methodologies
OFP-09-012-Morphological features of liver biopsies from The Gambia, West Africa: first pathology report from the "Gambia Hepatitis Intervention Study" by the International Agency for Research on Cancer
OFP-09-014-A nationwide pulmonary carcinoid tumour cohort collected from the Finnish clinical pathology integrated biobanks
OFP-10 | Joint Session: Pulmonary Pathology / Thymic and Mediastinal Pathology
OFP-10-001-Vascular endothelial growth factor (VEGF) and its receptors expression in lung carcinoids: clinicopathological correlation
OFP-10-002-Biomarkers in lung cancer: descriptive analysis of a centralised platform in Spain (Lungpath)
OFP-10-004-Interlaboratory variation in PD-L1 positivity in histological and cytological material of non-small cell lung cancer patients
OFP-10-006-The new gold standard for detection of theranostic gene rearrangements in thoracic oncology is born: one-year prospective routine LD-RTPCR in 328 newly-diagnosed lung adenocarcinomas
OFP-10-007-Birt-Hogg-Dubé (BHD) syndrome-associated lung cysts: histopathological analysis and differential diagnosis from miscellaneous cystic lung diseases
OFP-10-008-Combined assessment of tumour mutational load, CD8+ T cell infiltration, and expression of PD-L1 and HLA class I in small biopsy specimens to predict immunotherapy response in non-small cell lung cancer
OFP-10-009-Decreased PD-L1 immunostaining in cytological NSCLC specimens after fixation in an ethanol based fixative
OFP-10-010-Interstitial lung disease in systemic sclerosis is associated with autoimmunity to α1(V) chain of type V collagen
OFP-10-011-Multivariate survival analysis reveals RAD51 protein as a superior prognostic factor compared to tumor infiltrating lymphocytes and PD-L1 expression in patients with resected non-small-cell lung carcinoma
OFP-10-012-Copy number variation by NGS predict HER2 amplification status by ISH in NSCLC
OFP-10-014-Visceral pleural invasion by tumour size, cancer type and pathologist in 1,560 resections
OFP-10-015-Interobserver variation in the classification of thymic lesions including biopsies and resection specimens in an international digital microscopy panel
SPEC-02 | ESP & Arthur Purdy Stout Society: When ancillary tests lead you astray
SPEC-02-001-Case 1
SPEC-02-002-Case 2
SPEC-02-003-Case 3
SPEC-02-004-Case 4
SPEC-02-005-Case 5
SPEC-02-006-Case 6
SPEC-03 | French Society of Pathology: Liver biopsy in 2019
SPEC-03-001-New concepts in histopathology of NASH
SPEC-03-002-Is there still room for liver biopsy in viral hepatitis?
SPEC-03-003-Role of liver biopsy in cholestatic liver diseases
SY-17 | Endocrine Pathology: The new WHO classification of digestive neuroendocrine neoplasms (NEN) and beyond
SY-17-003-The new landscape of poorly differentiated NENs and mixed tumours
SY-17-004-Tumour heterogeneity and tumour progression in NENs
SY-17-005-New insights from lung NEN molecular data: new entities or new concepts?
SY-18 | Joint Session ESP & IARC: Classification of genetic tumour syndromes
SY-18-001-How the WHO Blue Books are handling hereditary cancer syndromes
SY-18-002-Overview of the digestive system syndromes
SY-18-003-Molecular classification from research to practice: two examples from the TCGA
SY-18-004-Familial colorectal cancer syndromes: the importance of registries and databases
SY-18-005-Lynch Syndrome and mismatch repair
SY-18-006-Identifying genetic syndromes – what is best practice
SY-19 | Cytopathology: Fall or rise of breast cytopathology
SY-19-001-Breast imaging: role and limitation
SY-19-002-Breast FNAC with rapid on-site diagnosis: potential & limitations
SY-19-003-Breast CNB: potential and limitations
SY-19-004-Prognostic and predictive factors from FNAC material using molecular tools
SY-19-006-Integrating the diagnostic of breast lesions
14:45 - 16:45
SC-08 | Endocrine Pathology: Diagnostic algorithms in thyroid pathology
SC-08-001-Thyroiditis
SC-08-003-Poorly differentiated and anaplastic carcinoma
SC-08-004-Sporadic and familial medullary carcinoma
SC-08-005-Rare flowers
SC-09 | Joint Session Autopsy Pathology & Euro-CNS & ESGFOR & History of Pathology: Security aspects for autopsies (+Business Meeting)
SC-09-001-Before gloves and antibiotics, a historical review from the daily life as a pathologist
SC-09-002-Biosafety in the autopsy room. Our experience
SC-09-003-Prion diseases and other health risks in neuropathology. How to handle autopsy material?
SS-08 | Joint Session Digestive Diseases Pathology / Infectious Diseases Pathology: Infectious lesions of the GI tract: new entities and pitfalls
SS-08-001-Case 1
SS-08-003-Case 3
SS-08-004-Case 4
SS-08-005-Case 5
SS-09 | Paediatric and Perinatal Pathology: Congenital tumours and pseudotumours (+Business Meeting)
SS-09-001-Case 1
SS-09-003-Case 3
SS-09-004-Case 4
SS-09-005-Case 5
SS-09-006-Case 6
SS-09-007-Case 7
SS-10 | Joint Session Ophthalmic Pathology & EOPS: Casuistic introduction in ophthalmic pathology for trainees and general pathologists
SS-10-002-Case 2
SS-10-003-Case 3
SS-10-004-Case 4
SS-10-006-Case 6
SS-10-007-Case 7
SS-10-008-Case 8
SS-10-009-Case 9
SS-11 | Cytopathology: Practical lessons from salivary gland cases: application of the Milan System
SS-11-001-Case 1
SS-11-003-Case 3
SS-11-004-Case 4
SS-11-005-Case 5
SS-11-007-Case 7
SS-11-008-Case 8
SS-11-009-Case 9
SY-20 | Soft Tissue and Bone Pathology: Diagnostic molecular pathology of bone and soft tissue tumours: techniques, translation and targets
SY-20-001-Genomic insights in sarcomas
SY-20-003-Prognosis and grading of tumours in the molecular era
SY-20-004-Molecular diagnosis of tumours in a clinical context: a case-based approach
SY-20-005-Molecular testing vs morphology in sarcomas: what is left to pathologists?
VM-06 | Uropathology: Glandular lesions and tumours in uropathology
VM-06-001-Case 1
VM-06-002-Case 2
VM-06-003-Case 3
VM-06-004-Case 4
VM-06-005-Case 5
VM-06-006-Case 6
17:15 - 19:15
MD-08 | New technologies
MD-08-001-Gene fusions in melanoma and/or skin
MD-08-002-NanoString transcript analysis for the detection of gene fusion events
OFP-11 | Joint Session: Soft Tissue and Bone Pathology / Infectious Diseases Pathology
OFP-11-002-Contribution of Raman Spectroscopy to diagnosis and grading of chondrogenic tumours
OFP-11-003-Dedifferentiated liposarcoma with myxoid liposarcoma-like features and amplification of DNA damage-inducible transcript 3 (DDIT3) - an important diagnostic pitfall
OFP-11-004-Immunohistochemical analysis of 33 cases of chondroblastomas: a single institutional experience from India
OFP-11-005-Superficial CD34+ fibroblastic tumour: clinicopathological, molecular and cytogenetic study of 4 cases
OFP-11-007-INSM1 immunohistochemical expression in a large cohort of Ewing sarcoma family of tumours
OFP-11-011-Validation of PCR for the diagnosis of leprosy in patients from Kiribas
OFP-11-012-In-situ protein expression analysis of cancer testis antigen SSX2
OFP-12 | Paediatric and Perinatal Pathology
OFP-12-001-Renal cell carcinoma in children and adolescent, a retrospective analysis of a cooperative European cohort
OFP-12-002-BRAF V600E mutation: a significant biomarker for prediction of disease in paediatric Langerhans cell histiocytosis
OFP-12-003-Histopathology of Steel syndrome due to new pathogenic variants of COL27A1 gene
OFP-12-004-Features of PLAP expression in placental structures during allogeniec pregnancy (surrogate maternity, oocyte donation) on the background of pre-eclampsia, as an indicator of exosomal trophoblast activity
OFP-12-005-The study of polymorphism of HLA genes as a predictor of the development of hypertensive complications of pregnancy
OFP-12-007-Perinatal acute respiratory failure: autopsy remains the best quality control tool
OFP-12-008-Body stalk anomaly: a rare lethal fetal anomaly, rarely reported in a dichorionic diamniotic twin pregnancy
OFP-12-010-Stillbirth and perinatal death: a retrospective study with application of ICD-PM to the autopsies performed between 2007 and 2018 in Coimbra
OFP-12-011-Metabolic reprogramming and altered isotope fractionation of cancerous cells of neural origin in the light of advanced atomic level Mass Spectrometry
OFP-12-012-Vascular anastomoses in monochorionic twin placentas: a pathomorphological study using CT
OFP-13 | Joint Session: Molecular Pathology / Haematopathology
OFP-13-001-Expression of SOX11 in mantle cell lymphoma is associated with increased angiogenesis and immunosuppressive microenvironment
OFP-13-002-Prognostic role of the microenvironment in follicular lymphoma treated with Rituximab and Rituximab+lenalidomide - results of a translational study of the SAKK35/10 trial
OFP-13-003-PDL1 in lymphomas with Hodgkin Reed Sternberg (HRS) morphology: a troubleshooter
OFP-13-004-Enhancer Zeste Homolog 2 (EZH2) expression is associated with a shorter time to the first systemic therapy in follicular lymphoma
OFP-13-006-Characterisation of atypical dMMR (deficient MisMatch Repair) tumours: a study from a large cohort of 4948 cases
OFP-13-008-Novel role of NMI (N-myc interactor) in chemotherapy response through a mitochondrial dysfunction mediated mechanism and as a potential target for breast cancer therapy
OFP-13-010-Methylation patterns in dysplasia in inflammatory bowel disease patients
OFP-13-011-XIST promoter methylation status as putative molecular biomarker for testicular germ cell tumours
OFP-13-012-Detection of EGFR mutations in ctDNA in plasma samples of NSCLC patients by two simultaneously applied methods
OFP-14 | Gynaecological Pathology
OFP-14-002-Detailed description of high-risk HPV in situ hybridisation patterns in endocervical adenocarcinoma and correlation with p16 immunohistochemistry
OFP-14-003-Programmed death-ligand 1 (PD-L1) in cervical invasive squamous cell carcinoma and squamous intra-epithelial lesions in HIV infected women: comparison with non-infected patients
OFP-14-006-Progenitor cells in ovario-fimbrial zone of female uterine adnexa: a potential clue for epithelial tumours pathogenesis
OFP-14-007-Diagnostic panel with p16, stathmin1 and laminin-gamma1 for serous tubal intraepithelial carcinoma
OFP-14-008-Relationship between microcystic, elongated and fragmented pattern of myometrial invasion and histopathological prognostic factors in endometrioid endometrial carcinoma
OFP-14-011-Neuroendocrine tumours involving the cervix: the role of p16 and HPV-genotyping
SC-10 | Uropathology: Diagnostic uropathology (+Business Meeting)
SC-10-001-Prostate cancer grading: over a decade after the 2005 modified system
SC-10-002-The big 5 in penile cancer
SC-10-004-Future pathological IO-Biomarker: pathologists beyond PD-L1
SC-10-005-Digital pathology approach to radical prostatectomy
SS-12 | Endocrine Pathology: Challenging cases in endocrine/neuroendocrine pathology (+Business Meeting)
SS-12-001-Case 1
SS-12-002-Case 2
SS-12-003-Case 3
SS-12-004-Case 4
SY-21 | Digestive Diseases Pathology: The new WHO classification of tumours of the digestive tract (+Business Meeting)
SY-21-001-Tumours of the upper GI tract
SY-21-002-Tumours of the lower GI tract
SY-21-003-Tumours of the liver and biliary tract
SY-21-004-Tumours of the pancreas
SY-22 | Joint Session History of Pathology / Ophthalmic Pathology: History of eye pathology: pioneers and technologies
SY-22-002-Historical review of retinoblastoma
SY-22-003-Cajal and his studies on retina